The content on this site is intended for healthcare professionals only
Animation depicting gene mutation and causes. Courtesy of CancerQuest at Emory University.
New classification for identifying HR myeloma based on cytogenetic abnormalities
Daratumumab, bortezomib/thalidomide/dexamethasone (D-VTd) and DARA maintenance shows benefit in transplant-eligible NDMM
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Revolutionising myeloma treatment through immune profiling
Treating relapsed multiple myeloma outside of use of T-cell redirected therapies
Guiding transplant decisions in multiple myeloma with MRD
Revolutionising multiple myeloma treatment with CAR T-Cell therapies
Post-diagnosis diet, nutrition and cancer prognosis
ESMO and WCLC: Latest developments in EGFR mutated NSCLC
